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Phosphodiesterases (PDEs) are critically involved in the
determination of intracellular cyclic nucleotide levels.
PDEs are heterodimers containing a conserved C-terminal
catalytic domain and an N-terminal regulatory domain.
Within their regulatory domain, 5 PDE families contain
GAF domains, which are potential cyclic nucleotide bind-
ing domains. cGMP is known to activate PDEs 2 and 5.
Also PDE10 and 11 contain GAF domains in their N
termini. However, the functional role of these domains
remains a matter of debate. In chimeric constructs of
PDE GAF domains and cyanobacterial adenylyl cyclase
catalytic domains, cAMP and cGMP activated constructs
containing the PDE10 and PDE11 GAF domains, respec-
tively. On the other hand, binding of cAMP and cGMP
was claimed not to activate the PDE10 and PDE11
holoenzymes.
Here we used synthetic ligands identified by fluores-
cence resonance energy transfer (FRET)-based analysis of
isolated GAF domains to demonstrate that PDE10 and
11 holoenzymes are activated by their GAF domains.
Furthermore, we show that PDE10 is activated by cAMP
and that PDE11 albeit sensitive to synthetic GAF ligands
is not activated by the physiological nucleotides cGMP
and cAMP.
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